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Abstract
Background: There is concern that recommending protein-enriched meal replacements as part of a weight
management program could lead to changes in biomarkers of liver or renal function and reductions in bone
density. This study was designed as a placebo-controlled clinical trial utilizing two isocaloric meal plans utilizing
either a high protein-enriched (HP) or a standard protein (SP) meal replacement in an outpatient weight loss
program.
Subjects/methods: 100 obese men and women over 30 years of age with a body mass index (BMI) between
27 to 40 kg/m2 were randomized to one of two isocaloric weight loss meal plans 1). HP group: providing 2.2 g
protein/kg of lean body mass (LBM)/day or 2). SP group: providing 1.1 g protein/kg LBM/day. Meal replacement
(MR) was used twice daily (one meal, one snack) for 3 months and then once a day for 9 months. Body weight,
lipid profiles, liver function, renal function and bone density were measured at baseline and 12 months.
Results: Seventy subjects completed the study. Both groups lost weight (HP -4.29 ± 5.90 kg vs. SP -4.66 ± 6.91 kg,
p < 0.01) and there was no difference in weight loss observed between the groups at one year. There was no
significant change noted in liver function [AST (HP -2.07 ± 10.32 U/L, p = 0.28; SP 0.27 ± 6.67 U/L, p = 0.820), ALT
(HP -1.03 ± 10.08 U/L, p = 0.34; SP -2.6 ± 12.51 U/L, p = 0.24), bilirubin (HP 0.007 ± 0.33, U/L, p = 0.91; SP 0.07 ±
0.24 U/L, p = 0.120), alkaline phosphatase (HP 2.00 ± 9.07 U/L, p = 0.240; SP -2.12 ± 11.01 U/L, p = 0.280)], renal
function [serum creatinine (HP 0.31 ± 1.89 mg/dL, p = 0.380; SP -0.05 ± 0.15 mg/dL, p = 0.060), urea nitrogen (HP
1.33 ± 4.68 mg/dL, p = 0.130; SP -0.24 ± 3.03 mg/dL, p = 0.650), 24 hour urine creatinine clearance (HP -0.02 ±
0.16 mL/min, p = 0.480; SP 1.18 ± 7.53 mL/min, p = 0.400), and calcium excretion (HP -0.41 ± 9.48 mg/24 hours,
p = 0.830; SP -0.007 ± 6.76 mg/24 hours, p = 0.990)] or in bone mineral density by DEXA (HP 0.04 ± 0.19 g/cm2,
p = 0.210; SP -0.03 ± 0.17 g/cm2, p = 0.320) in either group over one year.
Conclusions: These studies demonstrate that protein-enriched meals replacements as compared to standard meal
replacements recommended for weight management do not have adverse effects on routine measures of liver
function, renal function or bone density at one year. Clinicaltrial.gov: NCT01030354.
Background
Obesity and overweight have reached epidemic propor-
tions in the U.S. and increasingly around the world
[1,2]. A number of studies have suggested that protein
is the most satiating macronutrient and promotes the
retention of lean body mass. Meals with increased pro-
tein to carbohydrate ratios have been demonstrated to
increase satiety and decrease food intake [3,4] by com-
parison to standard protein intake. Increased protein
intake results in both improved weight loss and
improved maintenance of weight loss [5,6]. Therefore,
protein-enriched or supplemented meal replacements
have found their way into weight management practice.
There has been some concern that the long-term use
of high protein diets may damage liver function, renal
function, or reduce bone density [7,8]. While there are
studies of the effects of increased intake of animal pro-
tein in the diet, protein-enriched meal replacements
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have not been evaluated in comparison to standard meal
replacements in terms of effects on liver function, renal
function, and bone mineral density in free-living
populations.
Meal replacement (MR) is an important strategy in
designing structured diets for weight management due
to their simplicity, low cost, and convenience of protein-
enriched meal replacement shakes by comparison to fast
food meals [5,9,10]. Noakes et al [11] have shown that
meal replacements are as effective as structured weight-
loss diets. MR simplifies the weight loss plan by repla-
cing one or two meals a day with a product of defined
nutrient and calorie content. MR leads to increased
weight losses over twelve weeks compared to simply
restricting the intake of favorite food, and weight losses
have been shown to be maintained for up to 4 years
with the inclusion of one MR per day [12]. The present
study was designed to recommend isocaloric weight
management programs through the inclusion of either a
protein or a carbohydrate supplement to a standard
meal replacement powder to make either a standard or
protein-enriched meal replacement.
Methods
The study protocol was approved by the University of
California Los Angeles Institutional Review Board.
Healthy volunteers were recruited by public advertise-
ment. Subjects over 30 years of age with a body mass
index (BMI) between 27 to 40 kg/m2, and in good
health by history, physical examination, and basic
laboratory screening (complete blood count, serum che-
mistries, liver panel, and lipid panel) were selected for
the study. Subjects with type 2 diabetes or glucose intol-
erance were excluded as were individuals, who regularly
drank more than one alcoholic beverage daily.
One hundred men and women who met the selection
criteria were randomly assigned to either the HP (high
protein) or SP (standard protein) treatment. This was a
single-blinded study. Subjects were randomized in a 1:1
manner to either HP or SP diet using a computerized
random proportion model.
Caloric intake to achieve weight loss was based on a
500 Kcal deficit of the participants’ estimated resting
metabolic rate as determined by body composition ana-
lysis by DEXA. Diet plans were individualized per sub-
ject by the research dietitian. Subjects were instructed to
add to their meal replacements a set number of scoops
of either protein or carbohydrate from powder canisters
labeled as either A or B. The protein powder was mea-
sured with a calibrated scoop and subjects were
instructed regarding how many scoops to use for their
particular meal plan. Participants in the HP group
received a diet plan that provided 2.2 grams of protein
per kg of LBM while the diet for the SP group provided
1.1 grams of protein per kg of LBM. The meal energy
macronutrient composition in the HP group was
approximately 30% protein, 30% fat, and 40% carbohy-
drate. The macronutrient composition in the SP diet
was approximately 15% protein, 30% fat, and 55% carbo-
hydrate. Both groups received the same isocaloric MR
(Formula 1, Herbalife Intl., Los Angeles) with either a
protein supplement for the HP group (Performance Pro-
tein Powder, Herbalife Intl., Los Angeles) or a carefully
matched carbohydrate placebo containing maltodextrin
and flavoring for SP group.
Instructions were provided for preparation of the MR.
Subjects were advised to consume one MR in place of a
meal and the other as a snack daily for 12 weeks, then
one MR a day for an additional 40 weeks. All partici-
pants met individually with a registered dietitian at base-
line for dietary instruction, and at week 2, month 1, 2, 3,
6, 9 and 12 to provide counseling and follow-up. Quali-
tative food logs including the servings of macronutrients
and meal replacements were collected and reviewed
with subjects at each visit. Participants were weighed
and protein powder meal replacement products were
dispensed at each visit. Subjects were given general
advice for increasing their activity level with a goal of
30 minutes of aerobic exercise per day.
Body Weight
Subjects were weighed at each visit (Detecto-Medic;
Deteco-Scales; Brooklyn, NY) while wearing no shoes
after an overnight fast. Height was measured with a sta-
diometer (Detecto-Medic; Deteco-Scales; Brooklyn, NY)
at week 0. BMI was calculated as weight (kg)/height
squared (m).
Biochemistry
Blood samples after >10 hours of overnight fasting were
collected at months 0, 3, 6, and 12 for measurement of
lipid profiles, electrolytes, liver and renal function tests.
Twenty-four hour urine samples were collected at base-
line and week 52 for urinary urea nitrogen, creatinine,
calcium, phosphate excretions.
Plasma cholesterol was determined using standard
enzymatic methods. Reagents, standards and calibra-
tors were purchased from Pointe Scientific (Lincoln
Park, MI). The HDL or alpha cholesterol is derived
from the measurement on the supernatant following
the precipitation of apo B containing lipoproteins with
Heparin and MnCl2. The so-called LDL or beta lipo-
protein cholesterol is estimated from these data using
the Friedewald equation. All other tests were com-
pleted at Ronald Reagan Medical Center clinical
laboratory using standard methods. Urinary urea nitro-
gen was measured with an enzymatic method of Talke
and Schubert [13].
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Bone Density
Bone density was measured at baseline and 12 months
by Dual Energy X-ray Absorptiometry by a Lunar Prod-
igy DEXA (GE Medical Systems, Waukesha, Wisconsin).
Statistical Analysis
All variable transformations and statistical analyses were
performed using SAS version 9.2 [14]. We evaluated
effectiveness of the subject random allocation by com-
paring patient characteristics and baseline measurements
of the two study groups using t-tests (for continuous
variables) and Chi-square tests (for categorical variables).
We computed t-tests within each treatment group
using matched pair Analysis of Variance (ANOVA).
Univariate and multivariate Repeated Measures ANOVA
described within subject effects of changes over time for
the total study sample; between treatment group effects;
and changes over time by treatment group interactions.
Because outcome data was not available for participants
who dropped out of the study, we did not conduct
intention to treat analysis. All data are presented as
means ± standard deviation of the mean (SD).
Results
100 obese men and women were randomly assigned to
either a HP or SP MR diet plan. Fifteen subjects with-
drew from the study within the first week after rando-
mization due to inability to comply with the meal plan
(6 in the HP group and 9 in the SP group) and those
subjects were excluded from data analysis. Fifteen more
subjects (9 in the HP group and 6 in the SP group)
dropped out of the study during the 12 month trial due
to loss of follow-up and personal reasons. No subject
suffered any severe adverse event. Seventy subjects,
(thirty-five subjects in each group) completed the
12-month study. Subject characteristics in the two treat-
ment arms at baseline were not significantly different
(Table 1). Mean age was 49.4 ± 11.0 years. Mean BMI
at baseline was 34.43 ± 6.36 for HP group and 32.57 ±
4.10 kg/m2 for SP group.
Weight Loss
Subjects were weighed at baseline, 2 weeks, and monthly
thereafter. Baseline body weight was not significantly
different between these two groups. Both groups lost
significant amounts of weight at 12 months (4.29 ±
5.90 kg; SP -4.66 ± 6.91 kg, p < 0.01). (Figure 1) After
controlling for baseline weight, gender, and time period,
there was no significant difference between the two
treatment groups. For both dietary groups, BMI was sig-
nificantly lower at 12 months (HP = -1.53 ± 2.17; SP =
-1.77 ± 2.89 kg/m2). There were no significant differ-
ences in BMI changes between the two dietary groups.
Cholesterol, HDL, LDL, triacylglycerol
There were significant reductions in total cholesterol for
the HP group at 3 months (-15.20 ± 35.84 mg/dL, p <
0.05) and 6 months (-10.47 ± 30.46 mg/dL, p < 0.05) but
not for the SP group (-4.98 ± 25.14; -9.31 ± 30.26 mg/dL,
p > 0.05). The LDL concentration was significantly low-
ered at 3 months and 6 months ( -7.74 ± 21.92; -7.83 ±
23.06 mg/dL, p < 0.05) for the HP group but not for SP
group. There was significant elevation of HDL at month 6
for HP group only (2.53 ± 7.45 mg/dL, p < 0.05). The tria-
cylglycerol concentration was reduced significantly only
for the HP group at 3 months (-29.73 ± 58.22 mg/dL, p <
0.05). The difference between the two groups was not sig-
nificant for any of the parameters. (Table 2)
Table 1 Baseline characteristics of study participants
Characteristic HP (N = 44) SP (N = 41)
Demogrphic
Women, No. (%) 36 (81.8) 26 (63.4)
Age, mean (SD) 48.9 11.8) 49.7 (9.1)
Race, No. (%)
Asian 4 (9.1) 1 (2.4)
Black 9 (20.5) 8 (19.5)
Caucasian 26 (59.1) 28 (68.3)
Hispanic 4 (9.1) 2 (4.9)
Others 1 (2.2) 2 (4.9)
Weight Factors, mean (SD)
Body Weight, kg 93.5 (14.0) 92.7 (15.9)
BMI, kg/m2 34.7 (6.8) 34.3(10.3)
All values are mean ± SD. Subjects who dropped out of the study after
randomization were excluded. There were no significant differences between

















Figure 1 Body weight change in 12 months. Mean ± SD.
Subjects in HP and SP group both lost significant amount weight in
12 months compared with baseline. Open square: baseline, black
square: month 12, *P < 0.01 compared with baseline.
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Liver function
All subjects had normal ranges of AST, ALT, bilirubin,
and alkaline phosphatase at baseline. All those markers
remained in the normal range and did not change sig-
nificantly through the study (Table 3). No subject had
any liver markers out of the normal range during any
time of the study.
Renal function
No significant differences were found when comparing
12 month mean concentrations of serum creatinine, urea
nitrogen and urine nitrogen and creatinine clearance
within the groups and between the groups (Table 4).
Urinary protein excretion significantly increased in the
SP group but not in the HP group at month 12 (HP:
27.18 ± 105.33, mg/24 hours, p = 0.410; SP: 54.82 ± 83.35
mg/24 hours, p = 0.02). There was not any difference
between the groups.
Bone mineral density
No significant differences (p > 0.05) were observed at
12 months in total bone mineral density within-group
or between groups (Table 3).
Discussion
In this study, the energy deficit meal plan including
meal replacements resulted in significant weight loss
typical of meal replacement plans in both groups [15].
Since there was no run-in period, early dropouts were
significant but 70 out of 85 subjects were retained after
that point of the study. Because both diets were isocalo-
ric the amounts of weight loss were the same enabling a
meaningful comparison of the effects of the dietary
intervention on liver function, renal function, and bone
density in an outpatient setting. No special efforts were
made to assess compliance which could be considered a
limitation of the study. Compliance with diets is known
to decrease on an outpatient basis and is an unmeasured
effect that may account for the lack of findings of
adverse events in our study. Nonetheless, this was a
practical applied test of the issue as it would be encoun-
tered in people undertaking a weight management
regimen.
Concerns that diets high in protein may have deleter-
ious effects on renal function were not supported by the
results of this study. There was no difference in creati-
nine clearance with either dietary pattern during weight
reduction over one year. A previous study also reported
that creatinine clearance was not altered by dietary pro-
tein in the context of weight loss while nitrogen balance
was more positive in subjects who consumed a high
protein diet than in those who consumed a high carbo-
hydrate diet [16]. Skov et al [8] assessed changes in
renal function by measuring the glomerular filtration
rate (GFR) during high-protein and high-carbohydrate
diets over a 6-month period and found that the high
protein diet had no adverse effects on kidney function.
More recently, Knight et al. determined whether protein
intake influences the rate of renal function change in
women prospectively studied over an 11-year period [7].
The Nurses’ Health Study evaluated 1624 enrolled
women between the ages of 42 to 68 years in 1989 who
provided blood samples in 1989 and 2000. Ninety-eight
percent of women were white, while 1% were African
American. In multivariate linear regression analyses,
high protein intake was not significantly associated with
Table 2 Blood lipid concentrations
Cholesterol (mg/dL) Triacylglycerol (mg/dL) LDL (mg/dL) HDL (mg/dL)
HP SP HP SP HP SP HP SP
Baseline 198.85 ± 311.00 203.04 ± 39.08 136.07 ± 105.61 115.16 ± 55.57 116.88 ± 35.92 128.07 ± 36.28 54.34 ± 13.82 52.00 ± 10.56
Month 3 184.93 ± 272.00* 196.68 ± 36.36 106.24 ± 52.66* 113.59 ± 63.17 108.88 ± 36.54* 121.29 ± 36.36 54.83 ± 15.11 52.73 ± 11.19
Month 6 190.71 ± 279.00* 195.05 ± 38.38* 116.74 ± 74.19 106.64 ± 52.44 111.73 ± 26.79 * 119.74 ± 34.86 * 56.47 ± 15.47 * 53.95 ± 11.77
Month 12 188.33 ± 292.00 201.24 ± 37.60 119.33 ± 53.41 109.42 ± 63.78 132.07 ± 34.09 125.33 ± 32.78 54.63 ± 13.48 54.00 ± 11.48
All values are mean ± SD. There were no significant differences between groups. HP, high protein group; SP, standard protein group.
* p < 0.05 compare with baseline.
Table 3 Liver function tests
ALT (U/L) AST (U/L) Alkaline Phosphatase (U/L) Total Billirubin (mg/dL)
HP SP HP SP HP SP HP SP
Baseline 27.07 ± 13.97 28.84 ± 15.00 25.2 ± 11.44 23.33 ± 13.00 66.2 ± 37.00 71.88 ± 41.00 0.75 ± 0.26 0.77 ± 0.40
Month 3 25.4 ± 7.51 28.53 ± 15.00 24.23 ± 7.30 24.39 ± 16.00 69.64 ± 39.00 72.85 ± 18.58 0.75 ± 0.20 0.82 ± 0.20
Month 6 24.87 ± 11.22 27.23 ± 16.00 24.26 ± 14.00 23.44 ± 5.17 69.89 ± 19.13 72.21 ± 17.78 0.80 ± 0.25 0.83 ± 0.30
Month 12 24.1 ± 12.00 26.91 ± 14.23 23.00 ± 13.00 23.76 ± 14.00 71.48 ± 40.00 69.18 ± 18.65 0.76 ± 0.36 0.84 ± 0.40
All values are mean ± SD. There were no significant differences between groups. HP, high protein group; SP, standard protein group.
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change in estimated GFR in women with normal renal
function (defined as an estimated GFR ≥ 80 mL/min per
1.73 m2).
It has been suggested that a high protein diet may
generate acidosis because of the presence of ketone
bodies in the blood promoting calcium mobilization
from bone to buffer the blood and maintain pH. This
could promote urinary calcium loss [17,18]. There were
no deleterious effects of increased protein intake at
2.2 g/kg LBM on markers of bone turnover in our
study. In a 12- week study [19], a high protein diet
increased the bone turnover markers while calcium
excretion was decreased by 0.8 mmol/d. Evidence also
indicates that high protein intake particularly higher ani-
mal protein intake is associated with decreased bone
loss in older persons [20].
The trend of reduction in urinary calcium in this
study was also unusual because dietary protein metabo-
lism is associated with increased urinary calcium [21].
The high vegetable consumption with both dietary pat-
terns may prevent this because high vegetable intakes
have been shown to decrease urinary calcium [22]. An
increase in calcium excretion was observed with the
consumption of a high protein diet in the study by
Johnston et al [16] which stated that this was due to the
high calcium content of the high protein diet in their
study. However, we did not observe this high protein
pattern in which dietary calcium was very high.
Non-alcoholic fatty liver disease (NAFLD) is now the
most common liver disease and is strongly linked to
obesity and metabolic syndrome [23]. In middle aged
women in the UK, Liu and colleagues [24] found that
the relative risk of liver cirrhosis increased by 28% for
every 5 unit increase in BMI above 22.5 in each stratum
of alcohol consumption and estimated 17% of incident
or fatal liver cirrhosis is attributable to excess body
weight. Hart and colleagues [25] also show that being
overweight or obese and drinking alcohol has a synergis-
tic effect, which amplifies the insult to the liver and
greatly increases the risk of liver related morbidity and
mortality. Therefore, it is important to demonstrate that
an effective weight management program does not ele-
vate liver function tests and add insult to the liver. In
this study, there were no adverse effects on liver func-
tion tests at either level of protein intake.
The one-year duration of the study may have led to
reduced compliance to the meal plans. The study sub-
jects met for a total of 8 sessions with our dietitian.
These sessions were designed to support and encourage
participants to follow the meal plan including the MR.
At each visit, qualitative food logs for macronutrients
and meal replacement were collected and reviewed.
While we did not measure biochemical compliance, the
overall weight loss we observed suggest relatively good
compliance to our meal plans.
Noakes et al [19] reported that subjects with high
serum triacylglycerol (>1.5 mmol/L) lost more fat mass
with the high protein diet than with the high carbohy-
drate diet and suggesting a variation in responsiveness
to diet based on other metabolic factors such as the pre-
sence of insulin resistance which was not measured in
the current study.
As in many outpatient diet interventions long-term
compliance is undercut by some unmeasured factors
likely unrelated to the demonstrated satiety effects of
added protein. Therefore, the expected effects on
increased weight loss resulting from a high protein diet
were not seen in this study. In our previous study, pro-
tein-enriched meal led to increased fat mass loss based
on bioelectrical impedance analysis in spite of similar
overall weight loss as the standard protein meal plan
over 12 weeks [26]. The use of MR may have been the
major influence on the weight loss by simplifying their
weight loss efforts so that the power of the MR inter-
vention may have obscured the difference between the
weight losses of subjects using protein-enriched meal
plans by comparison to standard meal plans [5].
The Institute of Medicine (IOM) of the National
Academy of Sciences [27] has set acceptable macronu-
trient distribution ranges for carbohydrate (45%-65% of
Table 4 Renal function, calcium, phosphate excretion and bone mineral density
HP SP
Baseline Month 12 Baseline Month 12
Serum Creatinine (mg/dL) 0.82 ± 0.20 1.13 ± 1.85 0.87 ± 0.20 0.82 ± 0.18
Serum urea nitrogen (mg/dL) 12.37 ± 3.06 14.13 ± 5.77 12.14 ± 3.77 11.97 ± 3.73
Creatinne Clearance (mL/min) 129.78 ± 60.06 138.69 ± 40.39 116.89 ± 44.43 116.89 ± 42.84
Urine urea nitrogen (g/24 hr) 10.91 ± 4.49 12.22 ± 4.64 10.89 ± 4.73 9.58 ± 3.95
Urine Calcium (mg/24 hr) 184.68 ± 119.10 153.46 ± 77.07 25.2 ± 103.60 23.33 ± 75.74
Urine Protein (mg/24 hr) 141.25 ± 71.23 158.55 ± 88.82 114.39 ± 38.25 180.00 ± 86.56*
Bone mineral density (g/cm2) 1.00 ± 0.00 1.04 ± 1.19 1.03 ± 0.17 1.01.00 ± 0.03
All values are mean ± SD. There were no significant differences between groups. HP, high protein group; SP, standard protein group. *p < 0.05 compare with
baseline.
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energy), protein (10%-35% of energy), and fat (20%-35%
of energy; limit saturated and trans fats). These propor-
tions provide a range broad enough to cover the macro-
nutrient needs of most active individuals, but specific
carbohydrate and protein recommendations are also
typically made based on a g/kg body weight formula.
These ranges are 5 to 12 g of carbohydrate/kg body
weight and 1.2 to 1.8 g/kg body weight for protein
depending on the level of physical activity. Clearly, for
both the HP and SP group dietary protein intakes were
within this recommended range for protein intake.
Therefore, our research can only be applied to struc-
tured meal plans using protein-enriched shakes for their
ability to increase satiety and should not be interpreted
as a blanket endorsement of very high protein diets pop-
ular with some athletes exceeding the IOM recommen-
dations by including pure protein supplements, high fat
animal meats or other sources of organic acids and hid-
den fat which could adversely affect liver function, renal
function, or bone density.
Conclusions
In summary, both the HP and SP diets resulted in the
expected weight loss typical of an MR diet plan in free-
living individuals at 12 months. Both diets were well tol-
erated, sustainable, and did not result in any adverse
effects. There were no changes of liver function, renal
function or bone mineral density based on routine clini-
cal assessments.
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